Evidence map›Paper›PMID 18044710›Full record

ArticleJournal of cellular physiology2008

ESE-1 is a potent repressor of type II collagen gene (COL2A1) transcription in human chondrocytes.

Haibing Peng, Lujian Tan, Makoto Osaki, Yumei Zhan, Kosei Ijiri, Kaneyuki Tsuchimochi, Miguel Otero, Hong Wang, Bob K Choy, Franck T Grall and 4 more

Open access · greenAbstract readComparative Study
In one paragraph

Article in Journal of cellular physiology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
2.4field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 59 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Runx2 plays a central role in Osteoarthritis development.Journal of orthopaedic translation · 2020
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. New developments in the treatment of osteoarthritis - focus on biologic agents.Open access rheumatology : research and reviews · 2015
    Review
  14. Signaling pathways in cartilage repair.International journal of molecular sciences · 2014
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 1 country.

Haibing PengDepartment of Medicine, Beth Israel Deaconess Medical Center, New England Baptist Bone and Joint Institute, Boston, Massachusetts, USA.
Lujian Tan
Makoto Osaki
Yumei Zhan
Kosei Ijiri
Kaneyuki Tsuchimochi
Miguel Otero
Hong Wang
Bob K Choy
Franck T Grall
Xuesong Gu
Towia A Libermann
Peter Oettgen
Mary B Goldring
Beth Israel Deaconess Medical Center · USNew England Baptist Hospital · USBeth Israel Deaconess Hospital · USHospital for Special Surgery · USCornell University · US

Funding

Role of ESE1 Regulation of Type II Collagen in CartilageR01AG022021 · NIA · HOSPITAL FOR SPECIAL SURGERY · PI GOLDRING, MARY B · 2002 to 2014
$3.4M
Ese-1, a New Transcriptional Mediator of InflammationR01AI049527 · NIAID · BETH ISRAEL DEACONESS MEDICAL CENTER · PI LIBERMANN, TOWIA A · 2001 to 2005
$1.7M
The Role of Angiopoietin-1 in Rheumatoid ArthritisR01AR047952 · NIAMS · BETH ISRAEL DEACONESS MEDICAL CENTER · PI OETTGEN, J PETER PETER · 2002 to 2006
$1.3M
REGULATION OF MATRIX GENE EXPRESSION IN CHONDROCYTESR01AR045378 · NIAMS · BETH ISRAEL DEACONESS MEDICAL CENTER · PI GOLDRING, MARY B. · 1998 to 2001
$672k
NIAID NIH HHS R01 AI049527NIAID NIH HHS R01-AI49527NIAMS NIH HHS R01 AR047952NIAMS NIH HHS R01-AR45378NIAMS NIH HHS R01-AR47952NIA NIH HHS R01 AG022021NIA NIH HHS R01-AG022021
6 · The paper itself

Abstract

The epithelium-specific ETS (ESE)-1 transcription factor is induced in chondrocytes by interleukin-1beta (IL-1beta). We reported previously that early activation of EGR-1 by IL-1beta results in suppression of the proximal COL2A1 promoter activity by displacement of Sp1 from GC boxes. Here we report that ESE-1 is a potent transcriptional suppressor of COL2A1 promoter activity in chondrocytes and accounts for the sustained, NF-kappaB-dependent inhibition by IL-1beta. Of the ETS factors tested, this response was specific to ESE-1, since ESE-3, which was also induced by IL-1beta, suppressed COL2A1 promoter activity only weakly. In contrast, overexpression of ETS-1 increased COL2A1 promoter activity and blocked the inhibition by IL-1beta. These responses to ESE-1 and ETS-1 were confirmed using siRNA-ESE1 and siRNA-ETS1. In transient cotransfections, the inhibitory responses to ESE-1 and IL-1beta colocalized in the -577/-132 bp promoter region, ESE-1 bound specifically to tandem ETS sites at -403/-381 bp, and IL-1-induced binding of ESE-1 to the COL2A1 promoter was confirmed in vivo by ChIP. Our results indicate that ESE-1 serves a potent repressor function by interacting with at least two sites in the COL2A1 promoter. However, the endogenous response may depend upon the balance of other ETS factors such as ETS-1, and other IL-1-induced factors, including EGR-1 at any given time. Intracellular ESE-1 staining in chondrocytes in cartilage from patients with osteoarthritis (OA), but not in normal cartilage, further suggests a fundamental role for ESE-1 in cartilage degeneration and suppression of repair.

Indexed as

CartilageCells, CulturedChondrocytesChromatinCollagen Type IIDNA-Binding ProteinsElectrophoretic Mobility Shift AssayHumansImmunohistochemistryImmunoprecipitationInterleukin-1betaNF-kappa BPromoter Regions, GeneticProto-Oncogene Protein c-ets-1Proto-Oncogene ProteinsProto-Oncogene Proteins c-etsChromatinCOL2A1 protein, humanCollagen Type IIDNA-Binding ProteinsEHF protein, humanELF3 protein, humanETS1 protein, humanInterleukin-1betaNF-kappa BProto-Oncogene Protein c-ets-1Proto-Oncogene ProteinsProto-Oncogene Proteins c-etsRNA, MessengerRNA, Small InterferingTranscription Factors

Identifiers

PMID18044710
PMCPMC3937869
OpenAlexW1998621808

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.